OUR SOLUTIONS / ANEURYSM

Bridging the gap in assist devices

COMANECI™ is the only non-occlusive and temporary device for

wide-neck aneurysm treatment.

Request a demo

Minimize the risk and disruption to patients' lives with lasting results. COMANECI™ is the first active assist device–its added user control overcomes the limitations of conventional balloons and stents.

OUR SOLUTIONS / ANEURYSM

Bridging the gap in assist devices

COMANECI™ is the only non-occlusive and temporary device for wide-neck aneurysm treatment.

Request a demo

Minimize the risk and disruption to patients' lives with lasting results. COMANECI™ is the first active assist device–its added user control overcomes the limitations of conventional balloons and stents.

Minimize the risk and disruption to patients' lives with lasting results. COMANECI™ is the first active assist device–its added user control overcomes the limitations of conventional balloons and stents.

Stability doesn't

require implants

The temporary deployment of COMANECI™ provides the long-term support of a stent, achieving high packing density and 85% immediate complete occlusion compared to 79% with stent-assisted coiling.1

Avoiding implants like stents is preferable to allow the brain to heal naturally and minimize long-term stroke risks and bleeding complications.

Continuous

blood supply

Unlike balloons, COMANECI™  provides support without blocking blood flow to the brain. Clinicians can focus on accurate placement rather than the countdown to an ischemic event.

COMANECI™ demonstrates the highest complete occlusion and lowest complication rates. 

See the comparison

Continuous

blood supply

Unlike balloons, COMANECI provides support without blocking blood flow to the brain. Clinicians can focus on accurate placement rather than the countdown to an ischemic event.

COMANECI demonstrates the highest complete occlusion and lowest complication rates. 

See the comparison

Leaves no trace—

except SUCCESS

95% successful long-term occlusion and 1% retreatment rates show the lasting durability of treatment with COMANECI in both ruptured and unruptured wide-neck aneurysms.2

Unlock SUCCESS: The prospective study data

Leaves no trace—

except SUCCESS

95% successful long-term occlusion and 1% retreatment rates show the lasting durability of treatment with COMANECI in both ruptured and unruptured wide-neck aneurysms.2

Unlock SUCCESS: The prospective study data

Click on a tab below to learn more.

Clinical evidence
Product overview
How it works
In-Practice
Clinical evidence

PRODUCT OVERVIEW

COMANECI™ is designed with active, responsive technology to enable non-occlusive coil embolization procedures.

SPECIFICATIONS

Place an order Ask a product question Request an IFU

HOW IT WORKS

1. After positioning the catheters, DEPLOY the 1 st coil loop; then deploy COMANECI.

2. CONTINUE COILING – close and re-expand COMANECI before detaching each coil.

3. REMOVE the coiling catheter with COMANECI expanded. Remove COMANECI.

Place an order Ask a product question Request an IFU
Webinar banner

WEBINARS

Physician-led webinars are available to view on-demand. To watch a recording, please submit a request here.

Request to view
Dr. Josh Abecassis
DR. JOSH ABECASSIS | Louisville, KY
AMS CTA with incidental aneurysms
View the case →
Ravina et al.
DRS. KRISTINE RAVINA, IRA FINCH, BIRAJ PATEL, BENJAMIN YIM
The “Y” of COMANECI™ in a wide-necked ACA aneurysm
View the publication →
Dr. Sabih Effendi
DR. SABIH EFFENDI | Houston, TX
Stable coiling with COMANECI™ in an ICA aneurysm
View the case →
Place an order Ask a product question Request an IFU

Questions?

Reach out to learn more about our company and stroke solutions.

*90 consecutive patients in the U.S.

1. Lim, Jaims et al. “Coiling Variations for Treatment of Ruptured Intracranial Aneurysms: A Meta-Analytical Comparison of Comaneci-, Stent-, and Balloon- Coiling Assistance Techniques.” World neurosurgery vol. 175 (2023): e1324-e1340. doi:10.1016/j.wneu.2023.05.008

2. Jason M. Davies et al. Final Results of the SUCCESS Study presented at the ESMINT Congress; September 5, 2024; Marseille, France.

3. Comparison with a Balt Eclipse 6x7 mm